focusIR May 2024 Investor Webinar: Blue Whale, Kavango, Taseko Mines & CQS Natural Resources. Catch up with the webinar here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksEmpresaria Group Regulatory News (EMR)

Share Price Information for Empresaria Group (EMR)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 39.50
Bid: 38.00
Ask: 41.00
Change: 0.00 (0.00%)
Spread: 3.00 (7.895%)
Open: 39.50
High: 39.50
Low: 39.50
Prev. Close: 39.50
EMR Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Trading Update

26 Jan 2023 07:00

RNS Number : 8924N
Empresaria Group PLC
26 January 2023
 

26 January 2023

 

Empresaria Group plc

("Empresaria" or the "Group")

 

Trading Update and Notice of Results

 

 

Solid net fee income growth with full year profits expected to be in line with market forecasts

Empresaria (AIM: EMR), the global specialist staffing group, today provides a trading update for the financial year ended 31 December 2022 ahead of announcing its full year results on 28 March 2023.

 

Trading update

 

· Net fee income up 10% to £65.4m (up 8% in constant currency)

· Adjusted profit before tax and diluted earnings per share expected to be in line with market expectations

· Adjusted net debt of £7.9m, significantly better than market expectations

· Very strong performance from APAC and Offshore Services with net fee income up 75%, outweighing reductions in UK & Europe and Americas

· Communicated roadmap to deliver our ambition to double adjusted operating profit in the medium term

 

The first half of the year saw greater growth (+15%) reflecting a strong recovery in client demand particularly for permanent placements. While solid growth continued into the third quarter, growth eased in the fourth quarter reflecting a strong prior year comparative and some reduction in demand from specific clients in key sectors such as IT.

 

The Group has continued to invest for the future and communicated its roadmap to double adjusted operating profit to £20m in the medium term at a capital markets day in October 2022. The actions outlined remain on track and delivery against this plan continues to be a key focus.

 

Financial position

 

Adjusted net debt has significantly reduced at 31 December 2022 to £7.9m, £6.1m lower than 31 December 2021 and £2.9m lower than 30 June 2022. This reflects the profits generated by the Group in the year, along with a reduction in working capital requirements driven by a move in the weighting of revenue from temporary and contract to permanent placements. Headroom, excluding invoice financing, has increased to £17.9m.

 

 

Performance by sector

 

Net fee income by sector for the year ended 31 December was as follows:

£m

2022

2021

% change

% change (constant currency)*

UK & Europe

28.4

29.0

-2%

-2%

APAC

15.8

14.1

+12%

+12%

Americas

8.7

9.9

-12%

-19%

Offshore Services

13.5

7.7

+75%

+67%

Intragroup

(1.0)

(1.2)

-17%

-17%

Total

65.4

59.5

+10%

+8%

* The constant currency movement is calculated by translating the 2021 results at the 2022 exchange rates.

 

The UK & Europe saw mixed performances in 2022 with net fee income falling by 2%. In the UK, net fee income was up by 3% with strong growth in Professional, driven by increased permanent placement demand, offset by a weaker performance in IT. In our blue-collar Commercial businesses in Germany, we saw good recovery in our logistics operation which returned to growth after a challenging 2021, however, our temporary business was adversely impacted by client supply chain issues earlier in the year and higher sickness levels resulting in net fee income falling year on year.

 

In APAC, year-on-year net fee income growth of 12% reflected strong performances across most of the region with record net fee income in Singapore, Indonesia, Philippines, Thailand and Japan driven by growth in our Professional and IT sectors. Aviation failed to improve significantly in 2022, with recovery in our core Asia market lagging behind that in the US and Europe, reflecting the continued closure of China throughout 2022 and significant restrictions on travel to Japan.

 

In the Americas, net fee income fell by 12% with the main driver being the expected reduction in Healthcare in the US following an extremely strong 2021 that was driven by COVID-19 vaccination and testing related demand. Our US IT business also had a challenging year, particularly in the second half where our permanent recruitment offering was impacted by significant technology lay-offs at key clients.

 

Offshore Services had a very strong 2022 with net fee income up 75% year-on-year. UK demand, driven by healthcare, remained very strong and continued to grow throughout the year. The US was more challenging primarily driven by reduced demand from the IT sector. 

 

Rhona Driggs, CEO of Empresaria, commented:

 

"We are pleased with our overall progress and performance in the year. As we move into 2023, we look ahead with some caution given the wider economic environment, however, we are continuing to see strong demand in many of our markets largely driven by ongoing skills and labour shortages.

 

The transformation of the Group in recent years, along with the proven benefits from our diversification by geography and sector, improves our resilience and provides us with a strong foundation for growth. Executing our 'Roadmap to £20m' remains our key focus and we are confident we are well placed to deliver on our medium-term ambition to double our adjusted operating profit."

 

 

The information contained within this announcement is deemed by the Company to constitute inside information as stipulated under the UK version of the EU Market Abuse Regulation (2014/596) which is part of UK law by virtue of the European Union (Withdrawal) Act 2018, as amended and supplemented from time to time.

 

- Ends -

 

Enquiries:

Empresaria Group plc Rhona Driggs, Chief Executive OfficerTim Anderson, Chief Financial Officer

via Alma PR

Singer Capital Markets (Nominated Adviser and Broker) Shaun Dobson / James Moat

020 7496 3000

Cenkos Securities plc (Joint Broker) Katy Birkin / Charlie Combe (Corporate Finance)Michael Johnson / Jasper Berry (Sales)

020 7397 3900

Alma PR (Financial PR) Sam Modlin

Hilary Buchanan

Pippa Crabtree

020 3405 0205empresaria@almapr.com

 

Notes for editors:

§ Empresaria Group plc is a global specialist staffing group. We are driven by our purpose to positively impact the lives of people, while delivering exceptional talent to our clients globally. We offer temporary and contract recruitment, permanent recruitment and offshore services across six sectors: Professional, IT, Healthcare, Property, Construction & Engineering, Commercial and Offshore Services.

 

§ Empresaria is structured in four regions (UK & Europe, APAC, Americas and Offshore Services) and operates from locations across the world including the four largest staffing markets of the US, Japan, UK and Germany along with a strong presence elsewhere in Asia Pacific and Latin America.

 

§ Empresaria is listed on AIM under ticker EMR. For more information visit empresaria.com.

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
TSTFLFIALRIEFIV
Date   Source Headline
22nd May 20147:00 amRNSAGM Statement
13th Mar 20148:00 amRNSAwards pursuant to the Company's LTIP
11th Mar 20147:00 amRNSFinal Results
7th Mar 20143:42 pmRNSHolding(s) in Company
23rd Jan 20147:00 amRNSTrading Statement & Notice of Results
10th Dec 201311:48 amRNSHolding(s) in Company
10th Dec 20137:00 amRNSDirector/PDMR Shareholding
26th Sep 20133:03 pmRNSHolding(s) in Company
23rd Sep 201311:32 amRNSHolding(s) in Company
9th Sep 20137:00 amRNSAwards pursuant to the Company's LTIP
5th Sep 20137:00 amRNSHalf Yearly Report
30th Aug 20131:49 pmRNSDisposal of business
22nd Aug 20137:00 amRNSChange of Adviser and Notice of Results
8th Jul 20138:33 amRNSAcquisition of minority interest
23rd May 20131:00 pmRNSResult of AGM
23rd May 20137:00 amRNSAGM Statement
12th Apr 20137:00 amRNSAnnual Report and Accounts and Notice of AGM
20th Mar 20137:00 amRNSFinal Results
28th Jan 201311:02 amRNSAcquisition of minority interest in Skill House
17th Jan 20137:00 amRNSTrading Update
26th Oct 20127:00 amRNSAcquisition of minority interest in Headway
7th Sep 20124:12 pmRNSHolding(s) in Company
6th Sep 20127:00 amRNSHalf Yearly Report
15th Aug 20127:00 amRNSAcquisition of additional shares in MediradiX
13th Jul 201212:14 pmRNSAcquisition of further stake in subsidiary
31st May 201211:20 amRNSDirector Dealing
29th May 20121:00 pmRNSResult of AGM
29th May 20127:00 amRNSAGM Statement
22nd May 201210:19 amRNSDirector Dealing
21st May 20122:49 pmRNSDirctor Dealing
25th Apr 20121:55 pmRNSDirector Dealing
20th Apr 201210:08 amRNSNotice of AGM
21st Mar 20127:00 amRNSFinal Results
13th Mar 20127:00 amRNSSubsidiary mgmt change and option amendments
27th Jan 20127:00 amRNSAcquisition of further stake in subsidiary
24th Jan 201211:02 amRNSHolding(s) in Company
19th Jan 20127:00 amRNSTrading Update
22nd Dec 20117:00 amRNSAppointment of Broker
15th Dec 20114:27 pmRNSDirectorate Changes
8th Dec 20114:52 pmRNSHolding(s) in Company
6th Dec 20117:00 amRNSAcquisition of further stake in subsidiary
28th Oct 201111:05 amRNSHolding(s) in Company (replacement)
27th Oct 20115:39 pmRNSHolding(s) in Company
4th Oct 20114:04 pmRNSAwards pursuant to the Company's LTIP
8th Sep 20117:00 amRNSHalf Yearly Report
7th Jun 201112:55 pmRNSResult of AGM
7th Jun 201112:30 pmRNSAGM Statement
3rd May 201111:36 amRNSAnnual Report & Accounts and Notice of AGM
31st Mar 20117:00 amRNSFinal Results
31st Jan 20117:00 amRNSTrading Update

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.